United KingdomAdd to My Companies | Give a Referral for this Company | Print this Profile
The latest news, announcements and press releases from CrystecPharma.
Crystec are pleased to announce the opening of a new subsidiary, Nantong Crystec Pharmaceutical R&D Co. Ltd., and research facility, located at Haimen Science and Technology Park in Haimen City, Jiangsu Province, China.
Crystec’s new R&D centre has been established following an invitation to participate in the Yangtze Delta Advanced Drug Development platform jointly funded by the Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, and the Haimen government. The platform, which has received £550m equivalent in investment, is dedicated to accelerating pharmaceutical product innovation underpinned by advanced pharmaceutical excipients and drug delivery technologies. Crystec’s mSAS® technology will play a key role in enabling the development of new therapeutics, creation of value added medicines, and in simplification of formulations and manufacturing processes.
This is the News section of the company profile page for CrystecPharma on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.